Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Lipodystrophies
ADR ID BADD_A02556
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.07      Skin and subcutaneous tissue disorders NEC
23.07.01      Lipodystrophies
Description A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy. [MeSH]
MedDRA Code 10024606
MeSH ID D008060
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Lipodystrophy | Lipodystrophies
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01242Lamivudine0.003744%
BADD_D01352Maraviroc--
BADD_D01358Mecasermin--
BADD_D01366Medroxyprogesterone acetate0.000238%
BADD_D01550Nelfinavir mesylate--
BADD_D01557Nevirapine0.002652%
BADD_D01599Olanzapine0.000210%
BADD_D01699Pegvisomant--
BADD_D01799Ponatinib0.000112%
BADD_D01831Prednisolone0.000035%
BADD_D01834Prednisone0.000044%
BADD_D01905Raltegravir0.002472%
BADD_D01906Raltegravir potassium--
BADD_D01933Ribavirin--
BADD_D01940Rilpivirine0.000282%
BADD_D01952Ritonavir0.000735%
BADD_D01971Rosuvastatin0.000017%
BADD_D01989Saquinavir mesylate--
BADD_D02068Stavudine0.002117%
BADD_D02098Sumatriptan--
BADD_D02154Tenofovir--
BADD_D02155Tenofovir disoproxil--
BADD_D02156Tenofovir disoproxil fumarate--
BADD_D02226Tipranavir--
BADD_D02227Tipranavir disodium--
BADD_D02272Triamcinolone acetonide0.000401%
BADD_D02383Zidovudine0.011051%
The 2th Page    First    Pre   2    Total 2 Pages